<p>The National Institutes of Health National Institute on Aging awarded Nanode Therapeutics, Inc. a $496,150.30 firm fixed price Small Business Innovation Research Program Phase I contract to develop a Novel Non-Viral Nanoparticles Gene Delivery System for Alzheimer's Disease Gene Therapy. The work will be performed in Barrington, Rhode Island over a one year period ending September 29, 2023. The contract was awarded as a total small business set aside.</p>
The National Institute on Aging (NIA), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded an $852,000 firm fixed price delivery order contract to The Bioteam, Inc. (Bioteam) under the company's Multiple Award Schedule contract vehicle. Bioteam will perform an Alzheimer's Disease (AD) and Alzheimer's Disease-Related Dementias (ADRD) Data Ecosystem Landscape Assessment for NIA through November 15, 2023 from its place of performance...
This federal contract award was made by the National Institute on Aging (NIA), which is part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The contract, valued at $249,855.00, is a delivery order under the General Services Administration's (GSA) Multiple Award Schedule (MAS) contract vehicle. The contract was awarded to Lumina Corps Inc., a woman-owned small business, to provide planning, review, and support services in response to a...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $349,999.39 firm fixed price contract to Invivosciences, Inc. Biotech Toxicology, Human Tissue, Precison Drug Division under the Small Business Innovation Research Program Phase I Action. The contract is for the development of mechanism-based adult stem cell treatments to combat aging pathologies and will be performed in Madison, Wisconsin over a one year period ending August 31,...
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the Department of Health and Human Services, awarded a $16,999 firm fixed-price purchase order to Vectorbuilder Inc., a specialized biotechnology company, for large-scale 15 and ultra-purification packaging service for PAAV240227-1016XNQ. The contract, which does not utilize any set-aside designations, has a completion date of September 3, 2025. Vectorbuilder, a global leader in gene delivery...
This federal contract award, valued at $10,600.00, was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services. The contract was awarded to Vector Biosystems, Inc., doing business as Vector Biolabs, a minority-owned, small disadvantaged biotechnology company that provides gene delivery products and services. The contract is for the delivery of an AAV8-SPC512-MCHERRY construct, which is likely a gene...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Lifesensors Inc., doing business as Gene Transcription TECH. The contract is for applied/exploratory biomedical research, with a ceiling value of $149,550 and a period of performance through March 30, 2010. Lifesensors is a biotechnology company that conducts research on novel therapeutic approaches such as targeted...
The Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $599,980 firm fixed price contract to Tendel Therapies, Inc., a small business, for research and development services related to genetic adjuvants to promote durable anti-influenza stem antibodies in older adults. This contract was awarded under the NIH and Centers for Disease Control and Prevention's Small Business Innovation Research (SBIR) program,...
The Department of Health and Human Services' National Institutes of Health National Institute on Aging awarded a $60,000 firm fixed price delivery order contract to Life Molecular Imaging Limited for amyloid doses. Under this contract, Life Molecular Imaging Limited will provide amyloid doses to support the National Institute on Aging's research efforts. The contract has a period of performance of one year, running from September 15, 2023 through September 14, 2024. Life Molecular Imaging...
This is a firm fixed-price delivery order contract awarded by the National Institute on Aging (NIA), a civilian federal agency, to Scantox Neuro GMBH, a for-profit organization based in Austria. The contract, valued at $858,106.08, is for the experimental validation of candidate Alzheimer's disease treatments identified through multi-omics analyses. This work supports ongoing NIA research initiatives such as the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) and PREVENT-AD studies....